These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17229963)

  • 21. Devices for protecting the rectum during radiation therapy of prostate cancer.
    Rossi PJ; Johnstone PA
    J Urol; 2009 Mar; 181(3):947-8. PubMed ID: 19150560
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostate cancer: biological dose considerations and constraints in tele- and brachytherapy.
    Dörr W; Jaal J; Zips D
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():14-5. PubMed ID: 18166999
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate cancer.
    Sheinbein C; Teh BS; Mai WY; Grant W; Paulino A; Butler EB
    Urology; 2010 Sep; 76(3):728-33. PubMed ID: 19616279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer.
    Wilder RB; Barme GA; Gilbert RF; Holevas RE; Kobashi LI; Reed RR; Solomon RS; Walter NL; Chittenden L; Mesa AV; Agustin J; Lizarde J; Macedo J; Ravera J; Tokita KM
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):824-30. PubMed ID: 20510195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer.
    Fonteyne V; Villeirs G; Lumen N; De Meerleer G
    Radiother Oncol; 2009 Jul; 92(1):42-7. PubMed ID: 19356817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose escalation in image-guided, intensity-modulated radiotherapy of carcinoma prostate: initial experience in India.
    Swamy K; Sathiya Narayanan VK; Basu S; Maiya V; Achari R; Deshpande S; Bhangle J; Gupta KK; Babu N; Pawar S; Atre A; Balachandra K; Koppiker CB
    J Cancer Res Ther; 2009; 5(4):277-83. PubMed ID: 20160362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity.
    Jani AB; Su A; Milano MT
    Urology; 2006 Jan; 67(1):147-51. PubMed ID: 16413351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: analysis of toxicity.
    Coote JH; Wylie JP; Cowan RA; Logue JP; Swindell R; Livsey JE
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1121-7. PubMed ID: 19131179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Power against prostate cancer. Intensity-modulated radiation therapy and interstitial brachytherapy.
    Cash JC
    Adv Nurse Pract; 2006 Sep; 14(9):37-42. PubMed ID: 16972442
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer.
    D'Ambrosio DJ; Pollack A; Harris EE; Price RA; Verhey LJ; Roach M; Demanes DJ; Steinberg ML; Potters L; Wallner PE; Konski A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):671-7. PubMed ID: 18262085
    [No Abstract]   [Full Text] [Related]  

  • 31. Dosimetric consequences of the application of off-line setup error correction protocols and a hull-volume definition strategy for intensity modulated radiotherapy of prostate cancer.
    Baum C; Birkner M; Alber M; Paulsen F; Nüsslin F
    Radiother Oncol; 2005 Jul; 76(1):35-42. PubMed ID: 16019092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer.
    Vora SA; Wong WW; Schild SE; Ezzell GA; Halyard MY
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1053-8. PubMed ID: 17398023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.
    Zelefsky MJ; Chan H; Hunt M; Yamada Y; Shippy AM; Amols H
    J Urol; 2006 Oct; 176(4 Pt 1):1415-9. PubMed ID: 16952647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy.
    Smeenk RJ; van Lin EN; van Kollenburg P; Kunze-Busch M; Kaanders JH
    Radiother Oncol; 2009 Oct; 93(1):131-6. PubMed ID: 19523704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity.
    Fonteyne V; De Neve W; Villeirs G; De Wagter C; De Meerleer G
    Radiother Oncol; 2007 Aug; 84(2):156-63. PubMed ID: 17692976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensity modulated radiation therapy.
    Maddock PG
    Med Health R I; 2006 Feb; 89(2):76-8. PubMed ID: 16583667
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
    Al-Mamgani A; Heemsbergen WD; Peeters ST; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):685-91. PubMed ID: 18718725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose gradient near target-normal structure interface for nonisocentric CyberKnife and isocentric intensity-modulated body radiotherapy for prostate cancer.
    Hossain S; Xia P; Huang K; Descovich M; Chuang C; Gottschalk AR; Roach M; Ma L
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):58-63. PubMed ID: 20133073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensity-modulated radiotherapy of the prostate after cryotherapy: initial experience.
    Hepel JT; MacAusland SG; Long JP; Wazer DE; DiPetrillo T
    Urology; 2008 Dec; 72(6):1310-4; discussion 1314. PubMed ID: 18502482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
    Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
    Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.